USPSTF Urges Asymptomatic Bacteriuria Screen in Pregnancy
The USPSTF recommends screening pregnant women for asymptomatic bacteriuria (ASB) but not nonpregnant women or men.
Miscellaneous Ob/Gyn Conditions
USPSTF: Evidence Lacking for Elevated Lead Level Screening
The US Preventive Services Task Force has determined that the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic young children and pregnant women cannot be ascertained.
FDA Orders Manufacturers to Stop Selling Surgical Mesh for Transvaginal Repair of Pelvic Organ Prolapse
Manufacturers of surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse (POP) have been ordered by the Food and Drug Administration (FDA) to stop selling and distributing these devices.
FDA Issues Safety Labeling Change Order for Female Libido Pill
The Food and Drug Administration has denied Sprout Pharmaceutical’s request to remove the Boxed Warning and contraindication regarding the use of Addyi (flibanserin) with alcohol.
Review Links Adverse Events to Use of Herbal Meds in Pregnancy
Increased odds of preterm birth with almond oil; oral raspberry leaf linked to cesarean delivery
FDA Approves Novel Device for Treating Heavy Menstrual Bleeding
Channel Medsystems announced that the FDA has approved the Cerene Cryotherapy Device for the treatment of heavy menstrual bleeding.
Supply Change Announced for Contrast Agent Lipiodol
Guerbet LLC announced that the company will begin manufacturing Lipiodol (ethiodized oil) Injection in the US and will no longer import the product from France.
Vaginal Anti-Itch Spray Added to RepHresh Product Line
The RepHresh product line has been expanded to include RepHresh Cooling Relief Vaginal Anti-Itch Spray (Church and Dwight, Co.) to relieve external feminine itch and neutralize odor. The spray, which contains hydrocortisone 0.5%, is intended for topical use on the vulva. The non-benzocaine and paraben-free product can be sprayed in any orientation (including upside down)…
Prenatal Pesticide Exposure Linked to Increased Risk for Autism
Prenatal exposure to ambient pesticides within 2000m of maternal residence during pregnancy is associated with an increased risk for autism spectrum disorder.
Zulresso Approved as First Treatment for Postpartum Depression
The Food and Drug Administration (FDA) has approved Zulresso (brexanolone; Sage Therapeutics) injection for the treatment of postpartum depression in adult women, the first drug to be approved for this indication. Zulresso, an analogue of the endogenous human hormone allopregnanolone, is intended for continuous intravenous (IV) infusion over 2.5 days following a titration schedule. It…
